Strive is a bitcoin treasury company and institutional asset manager. Its primary activity is accumulating bitcoin on its balance sheet by raising capital through equity and debt issuances, with the goal of growing bitcoin holdings over time. As of mid-March 2026, Strive held 13,628 bitcoin and has not sold any. Strive also manages over $2.4B in AUM through an institutional asset management business, which generates recurring fee-based revenue and is targeted to operate near breakeven. Through its January 2026 acquisition of Semler Scientific, Strive also owns a small healthcare technology business that markets QuantaFlo, an FDA-cleared vascular testing device licensed to health insurers, physician groups, and hospitals — though this business is in decline, and Strive acquired it primarily to absorb Semler Scientific's existing bitcoin holdings. Strive's financial model centers on a "spread" approach: raise capital at low cost and deploy it into bitcoin, capturing the difference between financing costs and bitcoin's expected appreciation. Strive distinguishes between "beta" strategies — buying bitcoin at market price with capital raise proceeds — and "alpha" strategies — acquiring bitcoin at a discount through M&A. Strive uses bitcoin per share as its key performance metric and positions M&A as its primary differentiator from competitors that rely solely on open-market bitcoin purchases.